Szabo, Csaba

medical researcher, pharmacologist

Dr. Szabó was born in 1967. He graduated from Semmelweis University in 1992, and obtained a PhD in both physiology and pharmacology. From 1999, he is a doctor at MTA [the Hungarian Academy of Sciences]. He is a research fellow at the Clinical Experimental Research and Human Physiology Institute of Semmelweis University and at the Medical University of New Jersey, and the director of the Technology Transfer Office of Semmelweis University. He is an internationally acclaimed expert in the field of molecular pathophysiology of cell damage caused by free radicals, particularly in research concerning the role of nitrogen-monoxide, poly-ADP-ribose-polymerase and peroxi-nitrite in inflammations, cardiovascular diseases, and diabetes, and the pharmacology and development of new molecules intended to be used in related pre-patent medicines. He was involved in basic and applied research in England for an extended period of time (in a joint effort with Nobel laureate professor John Vane) and in the United States (in Cincinnati and Boston), maintaining scientific co-operation with all four medical universities in Hungary and the Experimental Medical Research Institute of the Hungarian Academy of Sciences in the meantime. He is a member of several international scientific bodies and the editorial boards of prestigious periodicals on pharmacology and molecular medicine. His 382 scientific publications appeared in the most respected international scientific periodicals. He is one of the most often quoted Hungarian researcher in scientific literature, and the ninth most quoted pharmacologist in the world.

Kamikaze molecules: the influence of free radicals from vitamin C to Viagra